We immunohistochemically determined the levels of CXCL5, elastase, TGF‐β, Axl, and Smad3L phosphorylation in HCC patient samples (n = 133) to assess the clinical relevance. This evidence concerns the gene CXCL5 and hepatocellular carcinoma.